Mitul A Mehta
Dr. Mitul Mehta research focuses primarily on using neuroimaging methods to study drug effects in human volunteers. The need for developing novel treatments is acute, and would benefit from a better understand of existing medications. His current work involves the use of experimental medicine models in healthy volunteers to test brain mechanisms at the systems level. This work has been utilized in assaying novel treatments. His work draws on developments in imaging acquisition and analysis technologies, and thus involves close collaboration with physicists and analysts. His recent studies have examined the effects of ketamine using multimodal imaging methodology. He currently heads the neuropharmacology group in the Department of Neuroimaging.